Iovance Biotherapeutics, Inc. Announces Closing of $603.7 Million Common Stock Public Offering
SAN CARLOS, Calif., June 02, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a late-stage biotechnology company developing […]